-
1.
公开(公告)号:US20220395552A1
公开(公告)日:2022-12-15
申请号:US17635127
申请日:2020-08-12
Inventor: Gwang LEE , Tae-Hwan SHIN , Yup KANG , Jong-Young KWAK , Dayeon LEE
IPC: A61K38/06 , A61K31/191
Abstract: The present invention relates to a composition for inhibiting the toxicity with respect to nanoparticles and particulate matters generated from the environment. Since it has been confirmed that a decrease in intracellular ATP, a decrease in cell viability, inflammation-induced morphological changes in cells and cell activation, which are induced by nanoparticles or environmentally-derived particulate matters, are inhibited by means of the composition of the present invention, the composition may be utilized as a reducing substance for the toxicity of nanoparticles and particulate matters.
-
2.
公开(公告)号:US20200283725A1
公开(公告)日:2020-09-10
申请号:US16803957
申请日:2020-02-27
Inventor: Jong-Young KWAK , Minho CHOI , Gwang LEE
Abstract: A method of preparing a polyvinyl alcohol nanofiber membrane includes a material for controlling cell specific adhesion, and a nanofiber membrane that can maintain cellular functions such as cell activity and growth is prepared by adding aqueous solutions containing a polyacrylic acid and a glutaraldehyde crosslinking agent in a polyvinyl alcohol and materials capable of enhancing or regulating cell adhesion, electrospinning, treating with hydrochloric acid vapor and dimethylformaldehyde solvent and treating with sodium hydroxide to control the cell adhesion.
-
公开(公告)号:US20190194715A1
公开(公告)日:2019-06-27
申请号:US16311161
申请日:2017-05-12
Inventor: Tae Hwan SHIN , Geetika PHUKAN , Man Jeong PAIK , Hyeon-Seong LEE , Hyung-Jin PARK , Da Yeon LEE , Gwang LEE
IPC: C12Q1/02 , C12Q1/6881 , C12Q1/6837
CPC classification number: C12Q1/025 , C12Q1/68 , C12Q1/6837 , C12Q1/6881 , C12Q2600/106 , C12Q2600/112 , C12Q2600/142 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16
Abstract: A method of assessing neurotoxicity of nanoparticles, includes: preparing a tissue or cell sample of mammal exposed to the nanoparticles; analyzing at least one polyamine metabolite selected from the group consisting of putrescine, N1-acetylspermidine, N8-acetylspermidine, N1-acetylspermine and spermine in the sample; and comparing expression degree of the polyamine metabolite with that of a control.
-
-